摘要
目的分析丁苯酞软胶囊结合依达拉奉用于治疗脑梗死的临床疗效。方法 2017年1—6月,于我院收治的脑梗死患者中选取500例,以治疗方式为依据,将其分为两组,两组患者均接受抗血小板聚集、改善循环等常规治疗,在此基础上,对照组患者单独采用依达拉奉治疗,观察组患者则联合应用依达拉奉与丁苯酞软胶囊治疗,对比两组临床疗效、神经功能缺损情况。结果观察组患者临床治疗总有效率为99.20%,高于对照组的76.00%,差异存在统计学意义,P<0.05;相较于治疗前,两组患者治疗后的BI评分有所提高,NIHSS评分有所降低,且观察组优于对照组,差异存在统计学意义,P<0.05。结论丁苯酞软胶囊结合依达拉奉治疗脑梗死的临床疗效显著,能有效改善患者神经功能缺损状况。
Objective To analyze the clinical efficacy of butylphthalide softgel combined with edaravone in the treatment of cerebral infarction. Methods From January to June 2017, 500 cases of cerebral infarction patients admitted to our hospital were selected. Based on the treatment method, they were divided into two groups. Both groups received antiplatelet aggregation and improved circulation. On the basis of conventional treatment, edaravone was used alone in the control group, and edaravone and butylphthalide soft capsules were used in the observation group. Clinical efficacy, neurological deficits, and quality of life were compared between the two groups. Results The total effective rate of clinical treatment in the observation group was 99.20%, were higher than 76.00% of the control group, the diference was statistically signifcant, P 〈 0.05; Compared with before treatment, the BI score of the two groups was improved, and the NIHSS score was decreased, and the observation group was better than the control group, the diference was statistically signifcant, P 〈 0.05. Conclusion Butyphthalide soft capsules combined with edaravone is efective in the treatment of cerebral infarction, can efectively improve the neurological defcit in patients.
作者
顾法欣
GU Faxin(Department of Pharmacology,Heze Municiple Hospital,Heze Shandong 274000,China)
出处
《中国继续医学教育》
2018年第25期106-108,共3页
China Continuing Medical Education
关键词
丁苯酞软胶囊
依达拉奉
脑梗死
临床疗效
常规治疗
butylphthalide soft capsule
edaravone
cerebral infarction
clinical efcacy
conventional therapy
